Clinical Trial Update: Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating radiotherapy planning with fluciclovine PET in patients with newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Fluciclovine (Fluciclovine)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Newly Diagnosed Glioblastoma | Phase 2 | Status: UNKNOWN